Thrombospondin-1/CD47 Blockade following Ischemia-Reperfusion Injury Is Tissue Protective

CD47 Expression on T Cell Is a Self-Control Negative Regulator of Type 1 Immune Response

(2014) S. Bouguermouh et al.   JOURNAL OF IMMUNOLOGY

Blockade of Thrombospondin-1-CD47 Interactions Prevents Necrosis of Full Thickness Skin Grafts

(2009) Jeff S. Isenberg et al.   ANNALS OF SURGERY

Functions and molecular mechanisms of the CD47–SIRPα signalling pathway

(2009) Takashi Matozaki et al.   TRENDS IN CELL BIOLOGY

Gene Silencing of CD47 and Antibody Ligation of Thrombospondin-1 Enhance Ischemic Tissue Survival in a Porcine Model

(2008) Jeff S. Isenberg et al.   ANNALS OF SURGERY

Thrombospondins: from structure to therapeutics

(2008) J. S. Isenberg et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling

(2008) Marika Sarfati et al.   CURRENT DRUG TARGETS

The chemical biology of nitric oxide: Implications in cellular signaling

(2008) Douglas D. Thomas et al.   FREE RADICAL BIOLOGY AND MEDICINE

Treatment of liver ischemia–reperfusion injury by limiting thrombospondin-1/CD47 signaling

(2008) Jeff S. Isenberg et al.   SURGERY

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling

(2007) J. S. Isenberg et al.   BLOOD